Category: Clinical Trial Update Region: North America · United States Company: Eli Lilly And Co United States

Eli Lilly Nixes Verzenios Phase 3 Her2-Positive Early Breast Cancer Trial

Eli Lilly Nixes Verzenios Phase 3 Her2-Positive Early Breast Cancer Trial
Eli Lilly Has Made The

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!